Other languages Amgen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
270 ^USD	+0.22%		+0.39%	-6.26%

04-26	Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe	MT
04-26	Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza	DJ

WOCHENVORSCHAU: Termine bis 10. Mai 2024	04-26
Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe	04-26
WOCHENVORSCHAU/29. April bis 5. Mai (18. KW)	04-26
Amgen to Submits Marketing Authorization Application to the European Medicines Agency	04-26
Wall Street : la 'tech' et le 'SOXX' en chute libre en hebdo	04-22
Wall Street : la 'tech' et le 'SOXX' en chute libre en hebdo	04-19
Neumora's early-stage schizophrenia drug study put on hold	04-15
Morgan Stanley Raises 2024, 2025 EPS Estimates for Regeneron Pharmaceuticals, Amgen	04-09
Boehringer to lay off salespeople as Humira biosimilar sales lag	04-05
Boehringer to lay off salespeople as Humira biosimilar sales lag	04-04
US takes next step in Medicare drug price negotiations with pharma companies	04-02
Amgen : Amazon, GameStop, Merck...les valeurs à suivre aujourd'hui à Wall Street	03-27
Amgen : s'allie à Gustave-Roussy sur les anticorps conjugués	03-27
ETF der Woche: Auf die Wende der Biotechs setzen	03-10
Amgen Presents New Research on Otezla at AAD 2024	03-09
L'ETF della settimana: scommettere sull'inversione di tendenza delle biotech	03-09
ETF van de week: inzetten op de ommekeer in de biotech	03-08
ETF de la semaine : miser sur le retournement des Biotechs	03-08
Amgen Announces 2024 Second Quarter Dividend, Payable on June 7,2024	03-06
Schweizer Leitindex erklimmt Jahreshoch	03-06

No results for this search